(Q37982584)

26 August 2017

title

Management of infective endocarditis: challenges and perspectives (English)

1 reference

26 August 2017

main subject

infective endocarditis

1 reference

5

1 reference

26 August 2017

4

Gilbert Habib

1 reference

26 August 2017

Franck Thuny

1

1 reference

26 August 2017

Dominique Grisoli

series ordinal

2

1 reference

26 August 2017

Frederic Collart

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

7 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

379

1 reference

26 August 2017

issue

9819

1 reference

26 August 2017

page(s)

965-975

1 reference

Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Changing patient characteristics and the effect on mortality in endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The Gulstonian Lectures, on Malignant Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Staphylococcus aureus endocarditis: a consequence of medical progress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Changing profile of infective endocarditis: results of a 1-year survey in France

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Incidence of infective endocarditis in the Delaware Valley, 1988-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

TREATMENT OF ACUTE BACTERIAL ENDOCARDITIS BY VALVE EXCISION AND REPLACEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

A systematic review of population-based studies of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

When should we operate on patients with acute infective endocarditis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Dramatic Reduction in Infective Endocarditis–Related Mortality With a Management-Based Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

COMBINED PENICILLIN AND HEPARIN THERAPY OF SUBACUTE BACTERIAL ENDOCARDITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Penicillin-resistant subacute bacterial endocarditis treated by a combination of penicillin and streptomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Bacterial endocarditis: survey of patients treated between 1945 and 1956

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Infective endocarditis: a changing disease. II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Combination antibiotic therapy for infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

In vivo antibiotic synergism: contribution of animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Long-term results of mitral valve repair in active endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Mitral valve repair provides improved outcome over replacement in active infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Contemporary results of mitral valve repair for infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Valve repair in acute endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Surgical treatment of active infective endocarditis: a continued challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Long-term results of surgery for active infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Surgery for active culture-positive endocarditis: determinants of early and late outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Early surgery in patients with infective endocarditis: a propensity score analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Health care-associated native valve endocarditis: importance of non-nosocomial acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Infective endocarditis: incidence and mortality in the North East Thames Region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Early predictors of in-hospital death in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Contribution of systematic serological testing in diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Negative blood cultures in infective endocarditis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Autoimmunohistochemistry: A New Method for the Histologic Diagnosis of Infective Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Impact of a Molecular Approach to Improve the Microbiological Diagnosis of Infective Heart Valve Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Streptococcus pneumoniae endocarditis: persistence of DNA on heart valve material 7 years after infectious episode

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Molecular diagnosis of infective endocarditis--a new Duke's criterion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Molecular technology in context: a current review of diagnosis and management of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Current trends in the molecular diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

A deadly aversion to pork

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Echocardiography in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Usefulness of real-time three-dimensional echocardiography for diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

(18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Possible role of PET/CT in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The Annexin code: revealing endocarditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Complicated left-sided native valve endocarditis in adults: risk classification for mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Prognostic stratification of patients with left-sided endocarditis determined at admission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Outcomes for endocarditis surgery in North America: a simplified risk scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The transcriptional programme of human heart valves reveals the natural history of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

A critical appraisal of the quality of the management of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Surgical Treatment of Active Aortic Endocarditis: Homografts Are Not the Cornerstone of Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Minimally invasive mitral valve surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Midterm results of valve repair with a biodegradable annuloplasty ring for acute endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

1 reference

7 January 2021

A change of heart: the new infective endocarditis prophylaxis guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Prophylaxis against infective endocarditis: summary of NICE guidance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Antibiotic prophylaxis of endocarditis: the rest of the world and NICE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

Vancomycin treatment of infective endocarditis is linked with recently acquired obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960755-1

7 January 2021

10.1016/S0140-6736(11)60755-1

Identifiers

DOI

1 reference

26 August 2017

1 reference